Clinical Trials Browser

Terminated × Prostatic Neoplasms × Vaccines × Clear all

NCT02362451 2022-03-18

Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer

Phase 2 Terminated

7 enrolled 10 charts

Prostatic Neoplasms